Humanized antibodies and compositions for binding sphingosine-1-phosphate
US8222373B2 · kind B2 · utility
0Cited by
103References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2008 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | May 24, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-S1P agents, particularly humanized monoclonal antibodies (and antigen binding fragments thereof) specifically reactive with S1P, compositions containing such antibodies (or fragments), and the use of such antibodies (or fragments), for example, to treat diseases and conditions associated with aberrant levels of S1P.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.